Michael Coyle, Executive Vice President and Group President, Cardiac and Vascular Group, will leave the company on Dec. 31, 2020 (news posted on December 15 2020).
Sean Salmon who is Executive Vice President and Group President of Medtronic Diabetes, will become Executive Vice President and President, Cardiovascular on Jan. 1, 2021 (news posted on December 15 2020).
Geoffrey Martha who is Chief Executive Officer, will become Chief Executive Officer and Chairman of the Board on Dec. 11, 2020 (news posted on October 7 2020).
Create an alert
to follow the executive moves at Medtronic Minimally Invasive Therapies.
Steris has announced the acquisition of Cantel Medical (posted on Jan 12, 2021).
Philips has announced the acquisition of BioTelemetry (posted on Dec 21, 2020).
Medtronic has acquired Medicrea (posted on Nov 18, 2020).
Medtronic Minimally Invasive Therapies has 953 competitors including Philips (Netherlands), Thermo Fisher Scientific (United States (USA)) and BD (United States (USA)). Medtronic Minimally Invasive Therapies is owned by Medtronic.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.